A share price of CME Group Inc [CME] is currently trading at $268.84, up 1.47%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CME shares have gain 1.28% over the last week, with a monthly amount glided 3.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on September 25, 2025, when Citigroup upgraded its rating to a Buy but kept the price target unchanged to $300 for it. Previously, UBS downgraded its rating to Neutral on July 24, 2025, and kept the price target unchanged to $305. On April 08, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $301 on the stock. Raymond James upgraded its rating to an Outperform but stick to its price target of $287 on March 10, 2025. Citigroup downgraded its rating to a Neutral and reduced its price target to $250 on January 06, 2025. Redburn Atlantic downgraded its rating to Neutral for this stock on October 08, 2024, but kept the price target unchanged to $244. In a note dated September 27, 2024, RBC Capital Mkts initiated an Sector Perform rating and provided a target price of $235 on this stock.
CME Group Inc experienced fluctuations in its stock price throughout the past year between $208.75 and $290.79. Currently, Wall Street analysts expect the stock to reach $292.33 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $268.84 at the most recent close of the market. An investor can expect a potential return of 8.74% based on the average CME price forecast.
Analyzing the CME fundamentals
Trailing Twelve Months sales for CME Group Inc [NASDAQ:CME] were 6.44B which represents 10.41% growth. Gross Profit Margin for this corporation currently stands at 0.87% with Operating Profit Margin at 0.65%, Pretax Profit Margin comes in at 0.75%, and Net Profit Margin reading is 0.58%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.14 and Total Capital is 0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 265.24 points at the first support level, and at 261.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 270.67, and for the 2nd resistance point, it is at 272.49.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CME Group Inc [NASDAQ:CME] is 1.02. As well, the Quick Ratio is 1.02, while the Cash Ratio is 0.01. Considering the valuation of this stock, the price to sales ratio is 15.03, the price to book ratio is 3.49 and price to earnings (TTM) ratio is 26.02.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Sep 25 ’25 when 262.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Sep 25 ’25 to buy 12.0 shares. Meanwhile, Sr MD General Counsel Marcus Jonathan L sold 392.0 shares on Sep 18 ’25.
